Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05595577 · ClinicalTrials.gov registry record · NA

Improving Exercise Capacity With a Tailored Physical Activity Intervention

A NA study of Quality of Life and Non-Hodgkin Lymphoma, sponsored by Wake Forest University Health Sciences.

Recruiting
Registry status
NA
Development phase
110
Enrollment target
2
Study locations

NCT05595577: Recruiting NA study of Quality of Life and Non-Hodgkin Lymphoma, sponsored by Wake Forest University Health Sciences.

NCT05595577 is a NA study of Quality of Life and Non-Hodgkin Lymphoma that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 110 participants, below the 452-participant average among 107 other Quality of Life trials with a reported enrollment target (76% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05595577, a NA study of Quality of Life and Non-Hodgkin Lymphoma, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.

RECRUITING
Registry status
NA
Development phase
110 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this research is to test whether participating in either a physical activity intervention or a series of educational classes will help to preserve exercise capability, heart function, brain-based activities (like memory), and quality of life. Participants will be randomized to 1 of 2 pathways: * First pathway consists of organized health workshops. These workshops are intended to provide information on topics such as proper nutrition, management of stress, sleep practices, and emphasis on a healthy lifestyle that may help the participants through cancer treatment. This pathway will also test whether stretching may help participants through cancer treatment. * Second pathway participants will take part in some unsupervised and some potentially supervised moderate activity sessions each week throughout participants' cancer treatment to take place either remotely or in person, depending on availability of facilities at the time visits are scheduled.

Primary Outcome

An analysis of covariance (ANCOVA) model will be used to assess post-intervention group differences in VO2, adjusted for baseline peak VO2.

Interventions

  • BEHAVIORAL Quality of Life Questionnaires
  • OTHER Exercise with Trainerize application
  • DIAGNOSTIC_TEST Cardiopulmonary exercise testing
  • DIAGNOSTIC_TEST MRI scan
  • BEHAVIORAL Cognitive and Brain Function Questionnaires

Study Locations (2)

North Carolina

  • Wake Forest Baptist Comprehensive Cancer Center - Winston-Salem

Virginia

  • Virginia Commonwealth University - Richmond

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2023-03-01
Est. Completion 2026-08-31
Phase NA
Wake Forest University Health Sciences

1,140 total trials

What NCT05595577 shows while recruiting

NCT05595577 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 452-participant average among 107 other Quality of Life trials with a reported enrollment target (76% lower).

The record links to 7 conditions, with Quality of Life appearing as the primary indexed condition, and to 5 interventions - of which Quality of Life Questionnaires is the first listed.

NCT05595577 reports a single indexed study location in North Carolina, Virginia.

Frequently Asked Questions

What is clinical trial NCT05595577 about?

NCT05595577 is a clinical study titled "Improving Exercise Capacity With a Tailored Physical Activity Intervention". The purpose of this research is to test whether participating in either a physical activity intervention or a series of educational classes will help to preserve exercise capability, heart function, brain-based activities (like memory), and quality of life. Participants will be randomized to 1 of 2...

What is the current status of trial NCT05595577?

This trial is currently recruiting. It is a NA study. The enrollment target is 110 participants. The study started on 2023-03-01. Estimated completion is 2026-08-31.

What conditions does trial NCT05595577 study?

This clinical trial studies the following conditions: Quality of Life, Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Stage II Breast Cancer, Stage III Breast Cancer.

What interventions are being tested in trial NCT05595577?

The interventions under investigation include: Quality of Life Questionnaires (BEHAVIORAL), Exercise with Trainerize application (OTHER), Cardiopulmonary exercise testing (DIAGNOSTIC_TEST), MRI scan (DIAGNOSTIC_TEST), Cognitive and Brain Function Questionnaires (BEHAVIORAL).

Who is sponsoring clinical trial NCT05595577?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05595577 being conducted?

This trial has 2 study locations across North Carolina, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Quality of Life

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05595577's enrollment target sits among peer trials

110 47th of 107 higher than 60 of 107 other Quality of Life trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Quality of Life trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01530373 · 110 participants · Phase 2

    Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients

  • NCT02379377 · 110 participants · Phase 1

    18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant

  • NCT02411773 · 110 participants · Phase 1

    Sympatholysis in Chronic Kidney Disease

  • NCT03190941 · 110 participants · Phase 1

    Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05595577, the US trial registry maintained by the National Library of Medicine. NCT05595577 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.